These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

417 related articles for article (PubMed ID: 9486679)

  • 61. A randomized, double-blind, four-arm parallel-group, placebo-controlled Phase II/III study to investigate the clinical efficacy of two galenic formulations of Polyphenon E in the treatment of external genital warts.
    Gross G; Meyer KG; Pres H; Thielert C; Tawfik H; Mescheder A
    J Eur Acad Dermatol Venereol; 2007 Nov; 21(10):1404-12. PubMed ID: 17958849
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Therapeutic approaches to genital warts.
    Beutner KR; Ferenczy A
    Am J Med; 1997 May; 102(5A):28-37. PubMed ID: 9217660
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Closing the feedback loop: an audit of the use of imiquimod for the treatment of genital warts.
    Brady S; Wilson JD
    J Eur Acad Dermatol Venereol; 2004 May; 18(3):314-7. PubMed ID: 15096142
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Topical immunomodulators for the treatment of external genital warts, cutaneous warts and molluscum contagiosum.
    Hengge UR; Cusini M
    Br J Dermatol; 2003 Nov; 149 Suppl 66():15-9. PubMed ID: 14616340
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The use of topical 5% imiquimod during pregnancy: a case series.
    Einarson A; Costei A; Kalra S; Rouleau M; Koren G
    Reprod Toxicol; 2006 Jan; 21(1):1-2. PubMed ID: 16039826
    [No Abstract]   [Full Text] [Related]  

  • 66. Human leukocyte interferon-alpha versus podophyllotoxin in cream for the treatment of genital warts in males. A placebo-controlled, double-blind, comparative study.
    Syed TA; Cheema KM; Khayyami M; Ahmad SA; Ahmad SH; Ahmad S; Ahmad SA
    Dermatology; 1995; 191(2):129-32. PubMed ID: 8520059
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Imiquimod: a cytokine inducer.
    Dahl MV
    J Am Acad Dermatol; 2002 Oct; 47(4 Suppl):S205-8. PubMed ID: 12271278
    [No Abstract]   [Full Text] [Related]  

  • 68. Evaluation of imiquimod 5% cream to modify the natural history of herpes labialis: a pilot study.
    Bernstein DI; Spruance SL; Arora SS; Schroeder JL; Meng TC
    Clin Infect Dis; 2005 Sep; 41(6):808-14. PubMed ID: 16107978
    [TBL] [Abstract][Full Text] [Related]  

  • 69. New treatments for genital warts less than ideal: abstract and commentary.
    Fife KH
    JAMA; 1998 Jun; 279(24):2003-4. PubMed ID: 9643868
    [No Abstract]   [Full Text] [Related]  

  • 70. Topical imiquimod cream 5% for resistant perianal warts in a renal transplant patient.
    Gayed SL
    Int J STD AIDS; 2002 May; 13(5):349-51. PubMed ID: 11972940
    [TBL] [Abstract][Full Text] [Related]  

  • 71. 5% topical imiquimod tolerance in transplant recipients.
    Ben M'barek L; Mebazaa A; Euvrard S; Frances C; Thervet E; Morel P; Menasché S; Legendre C; Lebbe C
    Dermatology; 2007; 215(2):130-3. PubMed ID: 17684375
    [TBL] [Abstract][Full Text] [Related]  

  • 72. A review of the applications of imiquimod: a novel immune response modifier.
    Syed TA
    Expert Opin Pharmacother; 2001 May; 2(5):877-82. PubMed ID: 12219723
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Treatment of keloid scars post-shave excision with imiquimod 5% cream: A prospective, double-blind, placebo-controlled pilot study.
    Berman B; Harrison-Balestra C; Perez OA; Viera M; Villa A; Zell D; Ramirez C
    J Drugs Dermatol; 2009 May; 8(5):455-8. PubMed ID: 19537368
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Pilot study of the effect of postoperative imiquimod 5% cream on the recurrence rate of excised keloids.
    Berman B; Kaufman J
    J Am Acad Dermatol; 2002 Oct; 47(4 Suppl):S209-11. PubMed ID: 12271279
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Imiquimod in clinical practice.
    Edwards L
    J Am Acad Dermatol; 2000 Jul; 43(1 Pt 2):S12-7. PubMed ID: 10861102
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Human papillomavirus (HPV) viral load and HPV type in the clinical outcome of HIV-positive patients treated with imiquimod for anogenital warts and anal intraepithelial neoplasia.
    Sanclemente G; Herrera S; Tyring SK; Rady PL; Zuleta JJ; Correa LA; He Q; Wolff JC
    J Eur Acad Dermatol Venereol; 2007 Sep; 21(8):1054-60. PubMed ID: 17714124
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Imiquimod as an immune response modulator in infectious conditions.
    Skinner RB
    Postgrad Med; 2002 Dec; 112(6 Suppl Using):8-16. PubMed ID: 19667608
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Experience in treating molluscum contagiosum in children with imiquimod 5% cream.
    Bayerl C; Feller G; Goerdt S
    Br J Dermatol; 2003 Nov; 149 Suppl 66():25-9. PubMed ID: 14616342
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Double-blind, randomized, placebo-controlled, prospective study evaluating the tolerability and effectiveness of imiquimod applied to postsurgical excisions on scar cosmesis.
    Berman B; Frankel S; Villa AM; Ramirez CC; Poochareon V; Nouri K
    Dermatol Surg; 2005 Nov; 31(11 Pt 1):1399-403. PubMed ID: 16416607
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Female genital warts: global trends and treatments.
    Gall SA
    Infect Dis Obstet Gynecol; 2001; 9(3):149-54. PubMed ID: 11516064
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.